Literature DB >> 24801765

Understanding the colloidal stability of the mesoporous MIL-100(Fe) nanoparticles in physiological media.

Elena Bellido1, Mazheva Guillevic, Tania Hidalgo, Manuel J Santander-Ortega, Christian Serre, Patricia Horcajada.   

Abstract

The colloidal and chemical stability of nanoparticles of the nontoxic and biodegradable iron(III) trimesate MIL-100(Fe) nanocarrier have been evaluated in the presence of a series of simulated physiological fluids for intravenous and oral administration. MIL-100(Fe) nanoparticles exhibit an appropriate colloidal stability and biodegradability, mainly dependent on both the nature of their physicochemical surface and the media composition, being a priori compatible with their biomedical use.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24801765     DOI： 10.1021/la5012555

Source DB:  PubMed          Journal:  Langmuir        ISSN： 0743-7463            Impact factor:   3.882


  18 in total

1.  ZIF-8 Degrades in Cell Media, Serum, and Some-But Not All-Common Laboratory Buffers.

Authors:  Michael A Luzuriaga; Candace E Benjamin; Michael W Gaertner; Hamilton Lee; Fabian C Herbert; Snipta Mallick; Jeremiah J Gassensmith
Journal:  Supramol Chem       Date:  2019-05-11       Impact factor: 1.688

2.  Aptamer-mediated up-conversion core/MOF shell nanocomposites for targeted drug delivery and cell imaging.

Authors:  Kerong Deng; Zhiyao Hou; Xuejiao Li; Chunxia Li; Yuanxin Zhang; Xiaoran Deng; Ziyong Cheng; Jun Lin
Journal:  Sci Rep       Date:  2015-01-19       Impact factor: 4.379

3.  New insights into the degradation mechanism of metal-organic frameworks drug carriers.

Authors:  X Li; L Lachmanski; S Safi; S Sene; C Serre; J M Grenèche; J Zhang; R Gref
Journal:  Sci Rep       Date:  2017-10-13       Impact factor: 4.379

4.  Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers.

Authors:  T Hidalgo; M Giménez-Marqués; E Bellido; J Avila; M C Asensio; F Salles; M V Lozano; M Guillevic; R Simón-Vázquez; A González-Fernández; C Serre; M J Alonso; P Horcajada
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

5.  Controlled Transdermal Release of Antioxidant Ferulate by a Porous Sc(III) MOF.

Authors:  Génesis Osorio-Toribio; Miriam de J Velásquez-Hernández; Paulo G M Mileo; J Antonio Zárate; Javier Aguila-Rosas; Gerardo Leyva-Gómez; Roberto Sánchez-Sánchez; Jonathan J Magaña; Mario Alberto Pérez-Díaz; Isabel Abánades Lázaro; Ross S Forgan; Guillaume Maurin; Enrique Lima; Ilich A Ibarra
Journal:  iScience       Date:  2020-05-11

Review 6.  Nanomedicines based on nanoscale metal-organic frameworks for cancer immunotherapy.

Authors:  Xiao-Fang Zhong; Xun Sun
Journal:  Acta Pharmacol Sin       Date:  2020-04-30       Impact factor: 6.150

7.  Selective Surface PEGylation of UiO-66 Nanoparticles for Enhanced Stability, Cell Uptake, and pH-Responsive Drug Delivery.

Authors:  Isabel Abánades Lázaro; Salame Haddad; Sabrina Sacca; Claudia Orellana-Tavra; David Fairen-Jimenez; Ross S Forgan
Journal:  Chem       Date:  2017-04-13       Impact factor: 22.804

8.  Nanometric MIL-125-NH₂ Metal-Organic Framework as a Potential Nerve Agent Antidote Carrier.

Authors:  Sérgio M F Vilela; Pablo Salcedo-Abraira; Isabelle Colinet; Fabrice Salles; Martijn C de Koning; Marloes J A Joosen; Christian Serre; Patricia Horcajada
Journal:  Nanomaterials (Basel)       Date:  2017-10-12       Impact factor: 5.076

9.  Multivariate Modulation of the Zr MOF UiO-66 for Defect-Controlled Combination Anticancer Drug Delivery.

Authors:  Isabel Abánades Lázaro; Connor J R Wells; Ross S Forgan
Journal:  Angew Chem Int Ed Engl       Date:  2020-02-04       Impact factor: 15.336

Review 10.  Size control over metal-organic framework porous nanocrystals.

Authors:  Checkers R Marshall; Sara A Staudhammer; Carl K Brozek
Journal:  Chem Sci       Date:  2019-09-12       Impact factor: 9.825
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.